HIV-associated neurocognitive disorders (HAND) are chronic complications of HIV infection in the central nervous system. Clinical presentations include asymptomatic neurocognitive impairment (ANI), mild neurocognitive impairment (MND), and HIV-associated dementia (HAD). In the era of combination antiretroviral therapy (cART), the prevalence of HAD has significantly decreased, but the rates of ANI and MND have increased, impairing patients’ daily functioning, medical adherence, employment, driving abilities, risk of HIV transmission, overall quality of life, and posing challenges to society, economy, families, and public health. This article reviews the latest research findings regarding the pathogenesis, clinical diagnosis and treatment, neuroimaging, and neuropsychological assessment of HAND, aiming to provide insights into the prevention and management of HAND.
References
[1]
Scanlan, A., Zhang, Z., Koneru, R., Reece, M., Gavegnano, C., Anderson, A.M., Tyor, W. (2022) A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment. Microorganisms, 10, Article 2244. https://doi.org/10.3390/microorganisms10112244
[2]
Clifford, D.B. (2019) Is Successful HIV Therapy a Pyrrhic Victory for the Brain? The Journal of Clinical Investigation, 129, 3052-3053. https://doi.org/10.1172/JCI127831
[3]
Mohamed, A.A., Oduor, C. Kinyanjui, D. (2020) HIV-Associated Neurocognitive Disorders at Moi Teaching and Referral Hospital, Eldoret, Kenya. BMC Neurology, 20, Article No. 280. https://doi.org/10.1186/s12883-020-01857-3
[4]
Song, F.L., Zhang, Y.L., Qiao, L.X., et al. (2012) Preliminary Screening of Neurocognitive Impairment in Chinese HIV-1 Infected People. Journal of Capital Medical University, 33, 610-615.
[5]
Kang, J., Liu, J., Zhang, Z.N., et al. (2014) Evaluation of Neurocognitive Function of Human Immunodeficiency Virus (HIV) Infected Patients by Montreal Cognitive Assessment Scale and Its Effect on Highly Effective Antiretroviral Therapy. Chinese Journal of Infectious Diseases, 32, 21-25.
[6]
Yang, X., Liu, D., Zhang, W.F., et al. (2018) Investigation on Neurocognitive Impairment in Untreated People with HIV Infection in Shenzhen. Journal of Tropical Medicine, 18, 21-25.
[7]
Ye, X.F., Chen, Z.R. and Zhao, T.T. (2015) Preliminary Investigation on Cognitive Function of AIDS Patients in Guangxi. Chongqing Medical Journal, 44, 1673-1675.
[8]
Wu, H., Song, A.X. and Huang, X.J. (2017) New Progress in Antiviral Treatment of AIDS. Beijing Medical Science, 39, 1191-1193.
[9]
Casaletto, K.B., Weber, E., Iudicello, J.E., et al. (2017) Real-World Impact of HIV-Associated Neurocognitive Impairment. In: Chiaravalloti, N.D. and Goverover, Y., Eds., Changes in the Brain. Springer, New York, 211-245. https://doi.org/10.1007/978-0-387-98188-8_10
[10]
Wang, D.M. (2013) Research Progress of Cognitive Dysfunction. Journal of Hebei Union University (Medical Edition), 15, 191-193.
[11]
Liu, T., Tan, J.Y., Hou, Z.J., et al. (2020) Research Progress on Pathogenesis and Diagnosis of HIV Related Neurocognitive Dysfunction. China AIDS STD, 26, 317-320.
[12]
Fernandes, N. and Pulliam, L. (2019) Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS. In: Cysique, L.A., Rourke, S.B., Eds., Neurocognitive Complications of HIV-Infection. Current Topics in Behavioral Neurosciences, Springer Nature, Switzerland, 77-103. https://doi.org/10.1007/7854_2019_100
[13]
Ma, Q., Vaida, F., Wong, J., Sanders, C.A., Kao, Y.T., Croteau, D., Clifford, D.B., Collier, A.C., Gelman, B.B., Marra, C.M., McArthur, J.C., Morgello, S., Simpson, D.M., Heaton, R.K., Grant, I., Letendre, S.L., CHARTER Group (2016) Long-Term Efavirenz Use is Associated with Worse Neurocognitive Functioning in HIV-Infected Patients. Journal of NeuroVirology, 22, 170-178. https://doi.org/10.1007/s13365-015-0382-7
[14]
Koay, W.L.A., Siems, L.V. and Persaud, D. (2018) The Microbiome and HIV Persistence: Implications for Viral Remission and Cure. Current Opinion in HIV and AIDS, 13, 61-68. https://doi.org/10.1097/COH.0000000000000434
[15]
Martin, C.R., Osadchiy, V., Kalani, A., et al. (2018) The Brain-Gut-Microbiome Axis. Cellular and Molecular Gastroenterology and Hepatology, 6, 133-148. https://doi.org/10.1016/j.jcmgh.2018.04.003
[16]
Ceccarelli, G., Fratino, M., Selvaggi, C., et al. (2017) A Pilot Study on the Effects of Probiotic Supplementation on Neuropsychological Performance and microRNA-29a-c Levels in Antiretroviral-Treated HIV-1-Infected Patients. Brain and Behavior, 7, e00756. https://doi.org/10.1002/brb3.756
[17]
Roomaney, R.A., van Wyk, B. and Pillay-van Wyk, V. (2022) Aging with HIV: Increased Risk of HIV Comorbidities in Older Adults. International Journal of Environmental Research and Public Health, 19, Article 2359. https://doi.org/10.3390/ijerph19042359
[18]
Yoshihara, Y., Kato, T., Watanabe, D., Fukumoto, M., Wada, K., Oishi, N., Nakakura, T., Kuriyama, K., Shirasaka, T. and Murai, T. (2022) Altered White Matter Microstructure and Neurocognitive Function of HIV-Infected Patients with Low Nadir CD4. Journal of Neurovirology, 28, 355-366. https://doi.org/10.1007/s13365-022-01053-8
[19]
Li, R.L. and Li, H.J. (2019) Research Progress of MRI Neuroimaging in HIV-Associated Neurocognitive Disorders. Chinese Journal of Magnetic Resonance Imaging, 10, 456-460. https://doi.org/10.12015/issn.1674-8034.2019.06.013
[20]
Cilliers, K. and Muller. C.J.F. (2021) Effect of Human Immunodeficiency Virus on the Brain: A Review. Anatomical Record, 304, 1389-1399. https://doi.org/10.1002/ar.24573
[21]
Li, R., Qi, Y., Shi, L., Wang, W., Zhang, A., Luo, Y., Kung, W.K., Jiao, Z., Liu, G., Li, H. and Zhang, L. (2021) Brain Volumetric Alterations in Preclinical HIV-Associated Neurocognitive Disorder Using Automatic Brain Quantification and Segmentation Tool. Frontiers in Neuroscience, 15, Article 713760. https://doi.org/10.3389/fnins.2021.713760
[22]
Van Wyhe, K.S., De Water, T.V., Boivin, M.J., et al. (2017) Cross-Cultural Assessment of HIV-Associated Cognitive Impairment Using the Kaufman Assessment Battery for Children: A Systematic Review. Journal of the International AIDS Society, 20, Article 21412. https://doi.org/10.7448/IAS.20.1.21412
[23]
Lin, S.P., Calcagno, A., Letendre, S.L. and Ma, Q. (2021) Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants. Current Topics in Behavioral Neurosciences, 50, 517-545. https://doi.org/10.1007/7854_2020_186
[24]
Chan, T., Marta, M., Hawkins, C. and Rackstraw, S. (2020) Cognitive and Neurologic Rehabilitation Strategies for Central Nervous System HIV Infection. Current HIV/AIDS Reports, 17, 514-521. https://doi.org/10.1007/s11904-020-00515-0
